SCHEMBL8204147

SCHEMBL8204147

Cc1ncc(CN2c3ccccc3CCC2C)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.44
CHRM4 P08173 2/20 0.44
CHRM1 P11229 2/20 0.44
CHRM3 P20309 1/20 0.44
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TAAR1 Q96RJ0 2/20 0.37
CXCR4 P61073 1/20 0.35
ESR1 P03372 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MTNR1A P48039 4/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
HRH1 P35367 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8209043 0.87 KMT2A (0.45) CHRM2CHRM4CHRM1CHRM3L3MBTL1
SCHEMBL8203612 0.83 ALDH1A1 (0.44) POLBSMN1; SMN2MEN1ALDH1A1LMNA
SCHEMBL8207883 0.80 TAAR1 (0.60) CHRM2CHRM4CHRM1CHRM3TAAR1
SCHEMBL3523933 0.75 CHRM2 (0.44) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL3526076 0.74 CHRM2 (0.46) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL8214872 0.74 TAAR1 (0.61) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL3526073 0.74 CHRM2 (0.46) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL3526071 0.74 CHRM2 (0.46) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL22262519 0.74 MTNR1A (0.56) CHRM2CHRM4CHRM1CHRM3POLB
SCHEMBL22262517 0.74 MTNR1A (0.56) CHRM2CHRM4CHRM1CHRM3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858652-B2 Substituted 4-imidazoles HOFFMANN-LA ROCHE INC. (US) 2010-12-28 US disclosed
US-7858652-B2 Substituted 4-imidazoles HOFFMANN-LA ROCHE INC. (US) 2010-12-28 US disclosed
US-20080139533-A1 SUBSTITUTED 4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 US disclosed
US-20080139533-A1 SUBSTITUTED 4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 US disclosed
WO-2008058867-A2 SUBSTITUTED 4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139533-A1 SUBSTITUTED 4-IMIDAZOLES TAAR1, TAAR5, TACR1 CHRM2 70/4885CHRM4 91/4885CHRM1 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.